CONJOINT ANALYSIS A TECNIQUE TO DEVELOP A QUESTIONNAIRE OF TREATMENT PREFERENCES IN PATIENTS WITH LUNG CANCER

Author(s)

Nuria Perulero, Bsc, Psychologist1, Felipe Cardenal, MD, Physician2, Ramón Garcia, MD, Physician3, Oscar Juan, MD, Physician4, Sergio Vázquez, MD, Physician5, Isidoro Barneto, MD, Physician6, Cristina Varela, Bsc, Pharmacoeconomic Specialist71IMS Health, Barcelona, Spain; 2 ICO. Hospital Duran i Reynals, L'Hospitalet de Llobregat, Barcelona, Spain; 3 Hospital General Universitario Gregorio Marañón, Madrid, Spain; 4 Hospital Arnau de Vilanova, Valencia, Spain; 5 Complexo Hospitalario Xeral Calde, Lugo, Spain; 6 Hospital General Universitario Reina Sofía, Córdoba, Spain; 7 Roche Farma, Madrid, Spain

OBJECTIVES: To know which attributes related to treatment administration are valued highly in patients with lung cancer through the conjoint analysis. METHODS: A literature review was carried out to identify the attributes related to treatment. There were 6 attributes:1-Time spent in the hospital for treatment administration. 2-Immediate toxicity. 3- Symptoms' control. 4- Confidence with the physician. 5- Survival. 6-Treatment administration. Taking into account these attributes we elaborated 16 hypothetic scenarios. Through interviews with 2nd line lung cancer patients we asked them to order by preferred scenario. RESULTS: 24 patients were interviewed, with a mean (SD) age of 60.8 (11.6) years. 58.3% were men. The mean range by priority order, that is to say, of priority 1 (maximum preference) to priority 16 (minimum preference), we observed that the chosen scenarios in the first place were N (No time spent in the hospital/No immediate toxicity/Moderate symptom control/Quite a lot of confidence with the physician/More than 6 months survival/Oral administration) and H (Spending 2 hours per day during one week in the hospital/No immediate toxicity/Total control of symptoms/Total confidence with the physician/Less than 3 months of survival/Oral administration), whereas the ones less preferred were M (Spending 2 hours per day during one week in the hospital/No immediate toxicity/No symptom control/Any confidence with the physician/From 3-6 month survival/Intravenous administration) and J (No time spent in the hospital/High immediate toxicity/No symptom control/Any confidence with the physician/Less than 6 months of survival/Intravenous administration). The factors that influence more on the treatment preferences were, symptoms' control (31% of the patients), confidence with the physician (21.6%) and immediate toxicity (18.7%). CONCLUSION: Through a conjoint analysis we may conclude that the most important attributes for the patients were symptoms' control followed by confidence with their physician.

Conference/Value in Health Info

2007-10, ISPOR Europe 2007, Dublin, Ireland

Value in Health, Vol. 10, No. 6 (November/December 2007)

Code

PCN71

Topic

Patient-Centered Research

Topic Subcategory

Stated Preference & Patient Satisfaction

Disease

Oncology

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×